Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Chromogenic Screening Plate Production for E. coli Increased

By LabMedica International staff writers
Posted on 15 Jun 2011
The current outbreak strain of the enterohemorrhagic Escherichia coli (EHCH) in Germany belongs to the Escherichia coli O104 serogroup. More...
Production and distribution of a chromogenic screening plate for rapid detection of extended spectrum β-lactamase-producing (ESBL) organisms, such as E. coli O104, has been increased.

In the past, most outbreaks of hemolytic uremic syndrome (HUS) have been associated with E. coli O157, but the current outbreak strain belongs to the E. coli O104 serogroup. The causative strain produces Shiga toxin 2 and shows high resistance to 3rd generation cephalosporins (due to the ESBL resistance mechanism), as well as broad antimicrobial resistance to, among others, trimethoprim/sulphonamide and tetracycline.

The Oxoid (Basingstoke, England) and Remel (Lenexa, KS, USA) include culture on Oxoid brilliance ESBL agar, which gives results within 24 hours.

Dr. Roger Stephan, Institute for Food Safety and Hygiene, University of Zurich (Switzerland), suggested a diagnostic strategy based on the capability of the VTEC O104 outbreak strain to produce an ESBL. He commented, "Positive fecal samples or food enrichment cultures can be streaked onto Brilliance ESBL agar. On this medium, ESBL-producing E. coli appear as blue colonies after 24 hr. incubation. Suspect colonies will then be confirmed by [polymerase chain reaction] PCR for the vtx genes. Since the prevalence of ESBL-producing E. coli in healthy people and food items should be low, this could really improve chances to isolate the strains responsible for the positive PCR screening."

Other methods of identification include direct toxin detection using the Remel ProSpecT Shiga Toxin E. coli microplate assay; isolation on media, such as Oxoid MacConkey Agar; toxin detection using the Oxoid VTEC-RPLA kit, following growth on Oxoid brain heart infusion agar; antimicrobial susceptibility testing on Oxoid Iso-Sensitest agar or Mueller-Hinton agar with cefpodoxime combination discs and identification using the DuPont Qualicon RiboPrinter microbial characterization system.

Oxoid and Remel are brands of Thermo Fisher Scientific.

Related Links:
Oxoid
Remel
Institute for Food Safety and Hygiene, University of Zurich


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.